Continuous Physiological Monitoring Devices for DCTs & Clinical Wards
Clinically validated, screenless, and smart ECG/PPG wearables engineered in Europe for uninterrupted remote trial data capture and high-compliance patient surveillance.
Architectural Paradigm of Medical Wearables in European Decentralized Clinical Trials (DCTs)
How continuous physiological data capture is replacing intermittent episodic spot-checks to establish valid digital endpoints in pharmaceutical research.
The Shift from Episodic Spot-Checks to Continuous Telemetry
In traditional clinical trial frameworks, physiological measurements are captured intermittently during scheduled clinical site visits. This snapshot methodology introduces severe sampling bias, fails to record transient cardiac events such as paroxysmal atrial fibrillation, and misses subtle physiological deterioration occurring during normal daily routines. As a CE Certified Clinical Trial Remote Data Collection Wearable Manufacturer in the Netherlands, Corsano Health bridges this observational deficit by enabling continuous, 24/7 multi-parameter surveillance.
By leveraging high-frequency sampling across photoplethysmography (PPG), single-lead electrocardiography (ECG), skin temperature, and 3-axis accelerometry, our wearable architecture captures the true physiological trajectory of trial participants. This continuous telemetry enables principal investigators and contract research organizations (CROs) to identify real-world digital biomarkers, measure drug safety profiles with unprecedented granularity, and lower patient attrition rates through comfortable, non-intrusive form factors.
Regulatory Compliance: EU MDR 2017/745 & FDA 510(k) Cleared
Consumer-grade fitness trackers lack the algorithmic rigour, signal fidelity, and quality management systems required for submission to regulatory bodies such as the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA). Corsano's medical smart bracelets—including the flagship CardioWatch 287—are manufactured under strict ISO 13485 quality management systems.
Certified under the stringent EU Medical Device Regulation (EU MDR 2017/745) by Notified Body Kiwa (CE 1984) and cleared via FDA 510(k), our devices deliver clinically validated medical metrics. Every algorithm for calculating heart rate variability (HRV), respiration rate, core-body skin temperature estimation, and arrhythmia detection has undergone rigorous clinical validation trials against gold-standard hospital reference monitors.
Multi-Sensor Integration & IP-Free Raw Data Export Capabilities
Multi-Wavelength PPG & Single-Lead ECG
Combines multi-channel green, red, and infrared optical PPG sensors with integrated dry-electrode single-lead ECG strips. Provides robust pulse wave analysis, continuous SpO2 estimation, and full rhythm strip acquisition for cardiac arrhythmia verification.
Up to 128 Hz Raw Signal Data Access
Unrestricted, IP-free export of raw accelerometer, optical PPG waveforms, ECG voltage samples, skin temperature, and Galvanic Skin Response (GSR). Empowers data scientists to build proprietary AI/ML algorithms and custom digital biomarkers.
Screenless "Digital Detox" Ergonomics
Purpose-built without a touchscreen display to maximize battery endurance (up to 20 days standby), prevent patient distraction, eliminate user interaction bias in clinical protocols, and deliver superior durability (IP68/5ATM waterproof ratings).
Deploying Remote Wearable Data Collection Across Dutch & European Healthcare Systems
From leading academic medical centres in Amsterdam and Rotterdam to home-based decentralized trials, our medical technology transforms patient monitoring workflows.
1. General Ward Continuous Patient Deterioration Monitoring
In traditional hospital wards across the Netherlands and Western Europe, nursing staff manually record vital signs every 6 to 8 hours. Between these manual rounds, early signs of clinical deterioration (such as impending sepsis, respiratory distress, or post-operative internal bleeding) often go unnoticed. By deploying Corsano's medical smart bracelets, general wards establish a continuous safety net.
The platform calculates automated Early Warning Scores (EWS / NEWS2) in real-time, sending automated notifications to central nursing dashboards whenever physiological thresholds are breached. This drastically reduces nurse administrative burden while reducing adverse ward events and ICU transfers.
2. Hospital-at-Home & Post-Discharge Ambulatory Follow-Up
With European healthcare policies increasingly prioritizing early hospital discharge to curb operational costs and lower bed occupancy rates, the Dutch medical ecosystem has pioneered "Hospital-at-Home" (Zorg in de eigen omgeving) models. Corsano's remote monitoring platform allows patients discharged after major surgery, heart failure episodes, or acute oncology treatments to return home safely while remaining under continuous surveillance.
The bracelet automatically synchronizes encrypted telemetry via a low-power Bluetooth gateway or patient smartphone application directly to hospital Electronic Medical Records (EMR), ensuring seamless clinical continuity.
3. Decentralized & Hybrid Clinical Trials for Global Pharma
Global pharmaceutical sponsors conducting Phase II-IV Decentralized Clinical Trials (DCTs) across the EU require standardized, GDPR-compliant data collection infrastructures. Our Netherlands-manufactured wearables serve as the primary telemetry collection endpoint, enabling trial subjects to participate from any geographic location.
Integrated eCOA (electronic Clinical Outcome Assessment) software modules allow clinical trial managers to pair subjective patient-reported outcome diaries directly with continuous objective biosensor data, creating audit-ready, time-stamped datasets.
4. Cardiac Arrest Early Warning & Arrhythmia Screening
As part of prestigious research consortia—such as the DETECT initiative funded by the Dutch Heart Foundation in collaboration with Radboud UMC, Erasmus MC, and Amsterdam UMC—our technology is actively utilized to advance early detection models for sudden cardiac arrest and lethal arrhythmias.
High-resolution optical PPG wave analysis paired with automated ECG rhythm strip triggers allows researchers to train sophisticated deep-learning models capable of recognizing early pre-arrest hemodynamic signatures.
Key MedTech Trends Shaping Remote Data Collection in the Netherlands & EU
Strict Harmonization Under EU MDR (2017/745)
The transition from MDD to EU MDR has raised regulatory barriers for wearable devices. Non-certified fitness trackers are strictly prohibited from collecting endpoint data for regulated clinical trials or clinical decision support. Netherlands-based exporters with verified notified body certifications (Kiwa 1984) offer pharmaceutical sponsors a compliant, low-risk path to EU market approval.
Rise of Digital Biomarkers & Algorithmic Endpoint Validation
Pharma sponsors are moving away from traditional surrogate endpoints toward complex digital biomarkers—such as nocturnal HRV recovery indices, nocturnal respiratory rate variance, and continuous gait activity profiles. Open raw data access at 128 Hz is now a mandatory requirement for data-science teams building proprietary biomarker algorithms.
Energy Harvesting & Ubiquitous Cellular Connectivity
Next-generation wearable development in the Netherlands focuses on autonomous power management. Active European research initiatives (such as the Eurostars LifeTime project) combine micro-light energy harvesting with Narrow-Band IoT (NB-IoT) connectivity, paving the way for maintenance-free wearables that eliminate manual charging altogether.
Why Global Healthcare Leaders & Clinical Researchers Partner with Corsano Health
Headquartered in the Netherlands with precision engineering facilities in Switzerland, Corsano Health delivers medical-grade wearable systems built on verified expertise, authority, and trust.
End-to-End European Quality & Manufacturing Integrity
Every Corsano smart bracelet is designed, manufactured, and quality-tested in certified ISO 13485 facilities in Switzerland and the Netherlands. By retaining full control over hardware engineering, firmware architecture, optical design, and algorithm development, we guarantee complete supply chain traceability, data integrity, and strict adherence to European manufacturing standards.
Open System Architecture: REST APIs, SDKs & EMR Interoperability
We eliminate vendor lock-in. Measured parameters and automated Early Warning Scores are exposed through fully documented RESTful APIs and mobile software development kits (SDKs). Our architecture integrates seamlessly into existing hospital EMRs (Epic, ChipSoft HiX, Cerner), central nursing consoles, and third-party remote patient monitoring (RPM) platforms.
Validated by World-Class Healthcare Institutions & Industry Leaders
Frequently Asked Questions by Procurement Officers & Trial Investigators
Partner with a Premier Medical Wearable Manufacturer in the Netherlands
Whether you are designing a decentralised clinical trial, implementing hospital-wide continuous ward monitoring, or co-developing novel AI digital biomarkers, our clinical specialists are ready to support your deployment.